Know Cancer

or
forgot password

Electronic Study for Anastrozole Pharmacovigilance Evaluation


N/A
N/A
N/A
Not Enrolling
Female
Early Breast Cancer

Thank you

Trial Information

Electronic Study for Anastrozole Pharmacovigilance Evaluation


Inclusion Criteria:



- Post-menopausal Early Invasive Breast Cancer Patients who are under anastrazole
treatment, who have normal renal and hepatic functions.

Exclusion Criteria:

- Metastatic breast cancer patients, previous hormonal therapy, other malignancies.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

Nejdet Uskent

Investigator Role:

Principal Investigator

Investigator Affiliation:

Kadir Has University Medical School

Authority:

Turkey: Turkish Republic Ministry of Health

Study ID:

ARI-IPEP-0104

NCT ID:

NCT00558168

Start Date:

January 2004

Completion Date:

July 2008

Related Keywords:

  • Early Breast Cancer
  • Anastrazole
  • safety
  • early breast cancer
  • Breast Neoplasms

Name

Location